»ó´Ü¿©¹é
±â»ç (Àüü 1,559°Ç)
[Sub Story] ±¹³» °¡À̵å¶óÀΰú ¹æÇâ ¸ÂÃç°¡´Â ±Þ¿©±âÁØ
HBsAg ¾ç¼º°£°æº¯ÁõÀ̳ª °£¼¼Æ÷¾ÏÀÌ ÀÖÀ» °æ¿ì AST ¶Ç´Â ALT¿Í ¹«°üÇÏ°Ô HBV DNA°¡ ¾ç¼ºÀ̸é Å׳ëÆ÷ºñ¸£ ¾Ë¶óÆ䳪¸¶À̵å(TAF...
ÀÓ¼¼Çü ±âÀÚ  |  2023-08-07 13:48
¶óÀÎ
[Sub Story] ÀüÀ¯ÀüÀÚÇü DAA º¹ÇÕÁ¦ Áß½É Ä¡·áÀü·« Á¦½Ã
Àü¹ÝÀû ¼±º°°Ë»ç¿ì¼± °¡À̵å¶óÀο¡¼­´Â 18¼¼ ÀÌ»ó ¼ºÀο¡ ´ëÇÑ Àü¹ÝÀûÀÎ ¼±º°°Ë»ç¸¦ ±Ç°íÇß´Ù. ÀÌ¿¡ °ü·ÃÇؼ­´Â ¹Ì±¹¿¹¹æ¼­ºñ½ºÅ×½ºÅ©Æ÷½º(USPSTF)¿Í ¹Ì±¹Áúº´°ü¸®¿¹¹æ¼¾ÅÍ(CDC)ÀÇ ±Ç°í»çÇ×°ú ÀÏ°üµÈ ¸Æ¶ôÀ¸·Î Á¦½ÃÇß´Ù°í ...
ÀÓ¼¼Çü ±âÀÚ  |  2023-08-07 13:21
¶óÀÎ
[Sub Story] CÇü°£¿° À¯ÀüÀÚ1¡¤2Çü ÃÊÄ¡·á DAA º¹ÇÕÁ¦ 8~12ÁÖ ±Ç°í
À¯ÀüÀÚ 1aÇü/1bÇüÃÊÄ¡·á ´ë»ó ȯÀÚ Áß °£°æº¯ÁõÀÌ ¾ø°Å³ª ´ë»ó¼º°£°æº¯ÁõÀÌ ÀÖ´Â °æ¿ì ±Û·¹Ä«ÇÁ·¹ºñ¸£/ÇǺ귻Ÿ½ººñ¸£ 8ÁÖ, º§ÆÄŸ½ººñ¸£/...
ÀÓ¼¼Çü ±âÀÚ  |  2023-08-07 10:27
¶óÀÎ
[Interview] ¡°Áö¼ÓÀû BÇü°£¿° Ä¡·á¸¦ À§ÇÑ ¿É¼Ç¡±
±¹³» BÇü°£¿°ÀÇ ÇöȲÀº ¾î¶»°Ô µÇ´Â°¡?±¹°¡¿¹¹æÁ¢Á¾»ç¾÷ ÀÌÈÄ BÇü°£¿° À¯º´·üÀº 1982³â 8.6%¿¡¼­ 1995³â ÀÌÈÄ 4.5%·Î Å©°Ô ÁÙ...
ÀÓ¼¼Çü ±âÀÚ  |  2023-08-07 10:04
¶óÀÎ
[Sub Story] ±¹³» NAFLD À¯º´·ü ºñ¸¸¡¤´ç´¢º´°ú ÇÔ²² »ó½Â Áß
NAFLD ¹ß»ý·ü´ëÇÑ°£ÇÐȸÀÇ °£Áúȯ¹é¼­(2023³â)¿¡ µû¸£¸é ¿¬±¸¹æ¹ý°ú Áø´Ü±âÁØ¿¡ µû¶ó Â÷À̸¦ º¸ÀÌÁö¸¸ NAFLD ¹ß»ý·üÀº 1000¸í´ç...
ÀÓ¼¼Çü ±âÀÚ  |  2023-08-07 09:57
¶óÀÎ
[Sub Story] NAFLD °íÀ§Ç豺 ¼±º°°Ë»ç ±Ç°í
NAFLD °íÀ§Ç豺 ¹× °Ë»çÀü·«°¡À̵å¶óÀο¡¼­´Â ¼ºÀÎ NAFLD ȯÀÚ Áß ÀÓ»óÀûÀ¸·Î À¯ÀÇÇÑ ¼¶À¯È­Áõ(F2~F4 ´Ü°è) ¹× °£°æº¯Áõ °íÀ§Çè...
ÀÓ¼¼Çü ±âÀÚ  |  2023-07-28 17:10
¶óÀÎ
[Sub Story] °ü·ÃÁúȯ Ä¡·á ÅëÇÑ NAFLD °ü¸® °­Á¶
NAFLD¡¤NASH À§Çè°¡À̵å¶óÀο¡¼­´Â ºñ¾ËÄڿüºÁö¹æ°£Áúȯ(NAFLD)°ú ºñ¾ËÄڿüºÁö¹æ°£¿°(NASH) À¯º´·üÀÌ ¼¼°èÀûÀ¸·Î ³ô¾ÆÁö°í ÀÖ°í...
ÀÓ¼¼Çü ±âÀÚ  |  2023-07-28 16:58
¶óÀÎ
[Deep in Guideline] HBV DNAº¸´Ù °£¼¶À¯È­ ¼Ò°ß¿¡ µû¶ó Ä¡·á °­Á¶
ÀÚ¿¬°æ°ú ±Ç°í»çÇסâ¸é¿ª°ü¿ë±â¸é¿ª°ü¿ë±â ȯÀÚ Áß BÇü°£¿° eÇ׿ø(HBeAg) ¾ç¼º, Ç÷û BÇü°£¿° ¹ÙÀÌ·¯½º(HBV) DNA ≥107...
ÀÓ¼¼Çü ±âÀÚ  |  2023-07-28 16:29
¶óÀÎ
[Drug Review] °¡³×µà¿À ĸ½¶, Áö¼ÓÀû ALT °³¼± Àü·«
°£±â´É°Ë»çÀÇ Á߿伺¿ì¸®³ª¶ó´Â °£¾Ï À§ÇèÀÌ ³ôÀº ¸¸Å­ ¸¸¼º °£Áúȯ °ü¸®°¡ Áß¿äÇÏ´Ù. °£ÀÌ ´Ü¹éÁú, ´ç, ºñŸ¹Î, Áö¹æ µî ¿µ¾çºÐ ´ë»ç, ...
ÀÓ¼¼Çü ±âÀÚ  |  2023-07-28 16:23
¶óÀÎ
[Late Breaking Studies] ½Ç·Î½ºÅ¸Á¹, ´ç´¢º´¡¤PAD µ¿¹Ý½Ã ÇÏÁöÀý´Ü À§Çè°¨¼Ò ½Ã»ç
°í·ÁÀÇ´ë À¯Ã¶¿õ ±³¼öÆÀ(°í´ë¾È¾Ïº´¿ø ¼øȯ±â³»°ú)Àº ÃÖ±Ù 'Journal of the American Heart Associati...
ÀÌ»óµ· ±âÀÚ  |  2023-07-27 11:51
¶óÀÎ
[Cover Story] Çѱ¹ÀÎ ³úÁ¹Áß, ¼­¾ç°ú À¯º´Æ¯¼º ´Ù¸£´Ù
AHA¡¤ASA °¡À̵å¶óÀÎÇöÀç±îÁö ±¹¿Ü¿¡¼­ ¹ßÇ¥µÈ ³úÁ¹Áß °ü·Ã °¡À̵å¶óÀÎÀº ¹Ì±¹½ÉÀåÇùȸ(AHA)¡¤³úÁ¹ÁßÇùȸ(ASA)ÀÇ ³úÁ¹Áß 2Â÷¿¹¹æ °¡...
ÀÌ»óµ· ±âÀÚ  |  2023-07-05 16:49
¶óÀÎ
[Sub Story] ¡°ICAS¡¤¼ÒÇ÷°üÁúȯ¡¤ÃâÇ÷¿¡ ÁÖ¸ñÇؾߡ±
¾Æ½Ã¾ÆÀΠƯ¼º°ú Ç×Ç÷¼ÒÆÇÄ¡·á¿ï»êÀÇ´ë ±èÁ¾¼º ±³¼ö(¼­¿ï¾Æ»êº´¿ø ½Å°æ°ú)°¡ Àú³Î¿¡ °ÔÀçÇÑ ³í¹®¿¡ µû¸£¸é, ¾Æ½Ã¾ÆÀÎ ³úÁ¹Áß À¯º´Æ¯¼ºÀ» °í·ÁÇÒ...
ÀÌ»óµ· ±âÀÚ  |  2023-07-05 16:43
¶óÀÎ
[Deep in Guideline] [2021 AHA¡¤ASA ³úÁ¹Áß 2Â÷¿¹¹æ °¡À̵å¶óÀÎ]
Ç÷¾Ð¡¤ÄÝ·¹½ºÅ×·Ñ Á¶Àý ±¹³»Áöħ°ú ´Ù¼Ò Â÷ÀÌ
³úÁ¹Áß 2Â÷¿¹¹æ ¸ÂÃãÇü °ü¸®°¡À̵å¶óÀο¡¼­ ¿ì¼± °­Á¶µÈ ºÎºÐÀº ȯÀÚ ¸ÂÃãÇü Àü·«ÀÌ´Ù. À̸¦ À§ÇØ È¯ÀÚ¿¡ ´ëÇÑ ¼¼ºÎÀûÀÎ Áø´Ü ºÎºÐÀ» ù ¹ø...
ÀÌ»óµ· ±âÀÚ  |  2023-07-05 16:39
¶óÀÎ
[Sub Story] [2022 ´ëÇѺÎÁ¤¸ÆÇÐȸ ½É¹æ¼¼µ¿ ȯÀÚ¿¡¼­ NOAC »ç¿ëÁöħ]
¿ÍÆĸ° Åõ¿© ¾Æ½Ã¾ÆÀο¡¼­ ³ú°æ»ö ¿¹¹æ î¸, ³úÃâÇ÷ À§Çè ÍÔ
CHA©üDS©ü-VAScNOACÀº ±¹³»¿Ü¿¡¼­ ºñÆǸ·¼º ½É¹æ¼¼µ¿ ȯÀÚÀÇ ³úÁ¹Áß ¿¹¹æÀ» ¸ñÀûÀ¸·Î ÀûÀÀÁõÀÌ Çã°¡µÅ ÀÖ´Ù. ´Ü ´ëºÎºÐÀÇ NOAC...
ÀÌ»óµ· ±âÀÚ  |  2023-07-05 16:31
¶óÀÎ
[Interview] ³úÁ¹Áß¡¤½É¹æ¼¼µ¿ µ¿¹Ý½Ã ±Þ¼º±â °æ±¸Ç×ÀÀ°íÄ¡·á¿¡ NOAC ÇýÅáè
Q. ½É¹æ¼¼µ¿ ȯÀÚÀÇ ³úÁ¹Áß ¿¹¹æ¿¡ ÀÖ¾î NOACÀÇ ¿ªÇÒ°ú ºñÁßÀº?´Ù¾çÇÑ ÀÓ»ó±Ù°Å¿¡ ±â¹ÝÇÑ Ç³ºÎÇÑ Ã³¹æ°æÇè¿¡ ºñÃç º¼¶§, ½É¹æ¼¼µ¿ ȯÀÚ...
ÀÌ»óµ· ±âÀÚ  |  2023-07-05 16:26
¶óÀÎ
[Interview] ¡°¿þ¾î·¯ºí ½ÉÀüµµ ±â±â, ½É¹æ¼¼µ¿ ¼±º°°Ë»ç ´ë¾ÈÀ¸·Î ±â´ë¡±
Q. ±¹³» ºÎÁ¤¸ÆÀÇ ÀÓ»óÀû ¿ªÇаú ºñÁßÀ» Á¤¸®ÇÑ´Ù¸é?Áúº´°ü¸®Ã»°ú ´ëÇѺÎÁ¤¸ÆÇÐȸ°¡ Á¦½ÃÇÑ °Íó·³ ±¹³» Àα¸ÃþÀÌ °í·ÉÈ­µÇ¸é¼­ ºÎÁ¤¸Æ À¯º´·ü...
ÀÓ¼¼Çü ±âÀÚ  |  2023-07-05 16:22
¶óÀÎ
[Sub Story] SPARCL¿¡¼­ IMPROVE-IT¡¤SPRINT-MIND±îÁö
½ºÅ¸Æ¾½ºÅ¸Æ¾ Ä¡·áÀÇ ³úÁ¹Áß ¿¹¹æÈ¿°ú¸¦ ÀÔÁõÇÑ »ç·Ê´Â SPARCL ¿¬±¸°¡ ´ëÇ¥ÀûÀÌ´Ù. SPARCL ¿¬±¸´Â LDLÄÝ·¹½ºÅ×·Ñ(LDL-C) Àú...
ÀÌ»óµ· ±âÀÚ  |  2023-07-05 16:16
¶óÀÎ
[Sub Story] AMI Çѱ¹ÀÎ, °íÇ÷¾Ð µ¿¹ÝÀ² ¾ÐµµÀû ¿ìÀ§
AMI Æò±Õ¿¬·É 60¼¼ À̻󱹳» ±Þ¼º ½É±Ù°æ»öÁõ(AMI) ȯÀÚÀÇ Æò±Õ¿¬·ÉÀº 64.0¼¼·Î ³ªÅ¸³µ´Ù. ½É±Ù°æ»öÁõ ºÐ·ù¿¡ µû¶ó Â÷À̸¦ º¸¿´´Âµ¥ STºÐÀý »ó½Â ±Þ¼º ½É±Ù°æ»öÁõ(STEMI) ȯÀÚ´Â 62.7¼¼, STºÐÀý ºñ»ó½Â...
ÀÌ»óµ· ±âÀÚ  |  2023-07-05 16:13
¶óÀÎ
[Sub Story] CAD¡æPCI¡æDAPT¡æSAPT ÀÌȯ¿¡¼­ Ä¡·á±îÁö
Dual Anti-Platelet TherapyPCI ÈÄ DAPT Àû¿ë½Ã Áß¿äÇÑ »ç¾ÈÀº 2Á¦º´¿ë ¾à¹°Ä¡·áÀÇ Àû¿ë±â°£ÀÌ´Ù. µÎ°³ÀÇ Ç×Ç÷¼Ò...
ÀÌ»óµ· ±âÀÚ  |  2023-07-05 16:09
¶óÀÎ
[Sub Story] °ü»óµ¿¸ÆÁúȯ ȯÀÚ¿¡°Ô NOACÀ̶õ?
ÃÊ°íÀ§Ç豺¿¡¼­ ´ÙÁß±âÀü ¾à¹°Ä¡·áATLAS ACS 2-TIMI 51 ¿¬±¸¸¦ ÁÖµµÇß´ø Michael Gibson ±³¼ö(¹Ì±¹ ÇϹöµåÀÇ´ë)´Â ±Þ¼º°ü»óµ¿¸ÆÁõÈıº(ACS) ȯÀÚ¿¡¼­ Ç÷Àü»ý¼º°ú ÁøÇàÀ» ¸·±â À§ÇÑ Àü·«À¸·Î ÀÌÁß°æ·Î...
ÀÌ»óµ· ±âÀÚ  |  2023-07-05 16:02
Back to Top